secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001477932-26-000714
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx receives NYSE American non-compliance notice for stockholders' equity; must submit plan by March 8, 2026
--------------------------------------------------------------------------------

- Received NYSE American notice on Feb 6, 2026 for failing $2M, $4M, $6M stockholders' equity thresholds due to sustained losses.
- Must submit compliance plan by March 8, 2026; deadline to regain compliance is August 6, 2027.
- Stock will trade under VNRX with ".BC" designation indicating "below compliance."
- If plan not submitted or accepted, NYSE American will commence delisting proceedings.
- No immediate impact on listing or business operations; company intends to submit a plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793226000714/0001477932-26-000714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793226000714/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-000714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer